Financials

  • Market Capitalization 7.96 B
  • Employee 315
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1022
IBRX
ImmunityBio, Inc. - Common Stock
7.88 USD+1.16%-9.43%+10.67%+184.48%8.25 B USD
1032
PCVX
Vaxcyte, Inc. - Common Stock
56.21 USD-1.44%-6.33%+13.40%+32.88%8.12 B USD
1057
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
61.98 USD+1.71%-7.80%+18.74%+56.34%7.75 B USD
1072
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
109.96 USD+2.30%-2.47%+20.91%-0.32%7.54 B USD

Noticias